IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Claims Against Cardiovascular Systems Inc. on B...
October 12 2015 - 1:04PM
Business Wire
Khang & Khang LLP announces that it is investigating claims
of potential misrepresentations by Cardiovascular Systems Inc.
(“Cardiovascular Systems” or the “Company”) (NASDAQ: CSII). The
investigation focuses on whether the Company and its officers
violated securities laws by issuing misleading information to
investors.
If you purchased shares of Cardiovascular Systems during the
Class Period, please contact Joon M. Khang, Esquire, of Khang &
Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by
telephone: (949) 419-3834, or by email at joon@khanglaw.com.
There has been no class certification in this case. Until
certification occurs, you are not represented by an attorney. You
may choose to take no action and remain a passive class member.
According to the complaint, on May 8, 2014, the Company received
a letter from the U.S. Attorney’s Office for the Western District
of North Carolina stating that Cardiovascular Systems is being
investigated for possible violations of the False Claims Act. On
July 8, 2015, Cardiovascular Systems further revealed that a
whistleblower lawsuit filed in 2013 had been unsealed alleging that
Cardiovascular Systems engaged in a fraudulent marketing scheme to
maximize profits through illegal kickbacks.
If you wish to learn more about this lawsuit, or if
you have any questions concerning this notice or your rights,
please contact Joon M. Khang, a prominent litigator for almost two
decades, by telephone: (949) 419-3834, or by email at
joon@khanglaw.com.
This press release may constitute Attorney Advertising in some
jurisdictions.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151012005962/en/
Khang & Khang LLPJoon M. Khang, Esq.Telephone:
949-419-3834Facsimile: 949-225-4474joon@khanglaw.com
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jul 2024 to Aug 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Aug 2023 to Aug 2024